Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Am J Pathol ; 185(5): 1275-85, 2015 May.
Artigo em Inglês | MEDLINE | ID: mdl-25791527

RESUMO

The molecular mechanisms underlying the hepatitis B virus (HBV) life cycle are poorly understood because of the lack of appropriate in vitro infection models. Herein, we report a highly effective in vitro HBV infection system using fresh human hepatocytes (HHs) isolated from chimeric mice with humanized livers. After the inoculation of sera collected from HBV-infected chimeric mice or patients to HHs, we measured levels of HBV DNA, mRNA, covalently closed circular DNA, and viral protein expression in HHs. We investigated the neutralization activity of hepatitis B immune globulin and the effects of siRNA against sodium taurocholate-cotransporting polypeptide and clathrin heavy chain on HBV infection. We confirmed the expression of viral antigens in HHs and the presence of extracellular HBV DNA and hepatitis B surface antigen. The maximum infection rate was approximately 80%. Lamivudine and hepatitis B immune globulin treatment reduced HBV DNA levels in a dose-dependent manner. Knockdown of sodium taurocholate-cotransporting polypeptide and clathrin heavy chain significantly reduced the levels of hepatitis B surface antigen. Infection was successfully established using different donor HHs and inocula. Elevation of extracellular HBV DNA levels and the increase of HBV-positive HHs were blocked by continuous hepatitis B immune globulin treatment, indicating virus spread in this model. Chimeric mouse-derived HHs provide a robust in vitro infection model that can completely support the HBV life cycle.


Assuntos
Modelos Animais de Doenças , Hepatite B/virologia , Hepatócitos/virologia , Animais , Pré-Escolar , DNA Viral/análise , Feminino , Técnicas de Silenciamento de Genes , Vírus da Hepatite B/crescimento & desenvolvimento , Humanos , Imuno-Histoquímica , Técnicas In Vitro , Lactente , Masculino , Camundongos , RNA Interferente Pequeno , RNA Viral/análise , Reação em Cadeia da Polimerase em Tempo Real
2.
J Biochem ; 147(3): 327-35, 2010 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-19880379

RESUMO

Fibronectin (FN) is a major extracellular matrix protein involved in various biological events. This study demonstrated that the third FN type III repeat (FnIII3) and several fragments containing the repeat promote cell spreading and migration of human dermal fibroblasts (HDFs), whereas the fourth repeat (FnIII4) did not. A variety of cell types also spread on FnIII3 in a cell-type-specific manner, but not on FnIII4. Immunofluorescence assays revealed that FnIII3 induced the organization of focal contacts and stress fibres in HDFs. Cyclic [RGDFV] peptides with a D-Phe residue, which are selective inhibitors of cell adhesion to vitronectin, inhibited HDF spreading on FnIII3 equally with GRGDS, indicating little involvement of alphaV-integrins in FnIII3 spreading. An anti-beta1 integrin mAb inhibited cell spreading on FnIII3 and FN. To our knowledge, this is the first demonstration that a novel domain of FnIII3 functions in cell spreading and migration through an interaction with unresolved beta1 integrin(s) in an RGD-dependent manner.


Assuntos
Movimento Celular , Fibronectinas , Animais , Antineoplásicos/farmacologia , Adesão Celular , Linhagem Celular , Derme/citologia , Fibroblastos/efeitos dos fármacos , Fibroblastos/fisiologia , Fibronectinas/química , Fibronectinas/fisiologia , Humanos , Integrina alfaV/metabolismo , Integrina beta1/metabolismo , Camundongos , Oligopeptídeos/farmacologia , Ligação Proteica/efeitos dos fármacos , Estrutura Terciária de Proteína , Proteínas Recombinantes de Fusão/biossíntese , Proteínas Recombinantes de Fusão/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...